Meet the John Quale Travel Fellows

Meet the John Quale Travel Fellows

2022 John Quale Travel Fellows

2020 John Quale Travel Fellows

2019 John Quale Travel Fellows

2018 John Quale Travel Fellows

2017 John Quale Travel Fellows

2016 John Quale Travel Fellows

  • Samuel Funt, MD, Memorial Sloan-Kettering Cancer Center
  • Matthew Mossansen, MD, Urologic Oncology Fellow, Massachusetts General Hospital
  • Tracy Rose, MD, University of North Carolina at Chapel Hill
  • Debasish Sundi, MD, University of Texas M.D. Anderson Cancer Center

2015 John Quale Travel Fellows

  • Abdul R. Banday, Ph.D., M.S. Postdoctoral Fellow, Laboratory of Translational Genomics National Cancer Institute, NIH NCI Division of Cancer Epidemiology and Genetics
  • Max Kates, M.D. Resident, Department of Urology Johns Hopkins Medical Institutions
  • Huyen T. Nguyen, Ph.D. Postdoctoral Researcher, Department of Radiology The Ohio State University
  • Randy Sweis, M.D. Fellow, Division of Hematology/Oncology The University of Chicago

2014 John Quale Travel Fellows

  • Philip Ho, MD, Urologic Oncology Fellow, University of Texas M.D. Anderson Cancer Center
  • Tim Lautenschlaeger, MD , Research Assistant Professor, Senior Radiation Oncology Resident, The Ohio State University
  • Young Lee, PhD, Postdoctoral Fellow, National Cancer Institute, Urologic Oncology Branch
  • Anirban Mitra, MD, PhD, Senior Research Associate, Department of Pathology and Laboratory Medicine / Center for Personalized Medicine, University of Southern California

2013 John Quale Travel Fellows

  • Richard Bambury, MD, BCh, BAO, Memorial Sloan-Kettering Cancer Center
  • Sima Porten, MD, MPH, MD Anderson Cancer Center
  • Srinivas Vourganti, MD, National Cancer Institute
  • Daniel Willis, MD, MD Anderson Cancer Center

2012 John Quale Travel Fellows

  • Arjun Balar, MD, an assistant professor at the New York University Cancer Center presented on targeted therapies and markers to predict response and prognosis for bladder cancer.
  • Jeffrey Bassett, MD, MPH, a fellow in urologic oncology at the Vanderbilt University Medical Center, discussed introducing tobacco screening into urology clinics and using the visit as a teachable moment among bladder cancer survivors.
  • Eugene Lee, MD, a urologic oncology fellow at the University of Texas MD Anderson Cancer Center, talked about driving laboratory science based on patient needs in bladder cancer – especially adjunct therapies to BCG and chemotherapy.
  • Armine Smith, MD, a urologic oncology fellow at the National Cancer Institute, presented on the need for combination targeted therapy in treating bladder cancer.